Hypothesis

15 Matching Annotations

Feb 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Navitoclax, a Bcl-2/xL inhibitor, and YM155, a survivin inhibitor, in combination with carboplatin, effectively inhibit ovarian cancer tumor growth

1
1. scibot 04 Feb 2026
  
  in Public
  
  RRID: CVCL_2690
  
  DOI: 10.1158/1535-7163.MCT-23-0863
  
  Resource: (RRID:CVCL_2690)
  
  Curator: @bandrow
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12316570/
Oct 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Auranofin synergizes with cisplatin in reducing tumor burden of Notch-dependent ovarian cancer

1
1. scibot 16 Oct 2025
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1158/2767-9764.CRC-25-0190
  
  Resource: (RRID:CVCL_2690)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12512110/
Aug 2025
www.biorxiv.org www.biorxiv.org

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer

1
1. scibot 20 Aug 2025
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1101/2025.08.10.669554
  
  Resource: (RRID:CVCL_2690)
  
  Curator: @dhovakimyan1
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

biorxiv.org/content/10.1101/2025.08.10.669554v1
Jan 2025
www.nature.com www.nature.com

Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage

1
1. scibot 16 Jan 2025
  
  in Public
  
  CVCL_2690
  
  DOI: 10.1038/s41556-024-01557-x
  
  Resource: (RRID:CVCL_2690)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

nature.com/articles/s41556-024-01557-x
Jun 2024
www.cell.com www.cell.com

CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer

1
1. scibot 29 Jun 2024
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1016/j.isci.2024.109978
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

cell.com/iscience/abstract/S2589-0042(24)01200-8
Apr 2024
www.nature.com www.nature.com

Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade

1
1. scibot 03 Apr 2024
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1038/s41467-024-47069-y
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

nature.com/articles/s41467-024-47069-y
Nov 2023
www.sciencedirect.com www.sciencedirect.com

Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma

1
1. scibot 02 Nov 2023
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1016/j.celrep.2023.113307
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124723013190
Jun 2023
www.nature.com www.nature.com

Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation

1
1. scibot 24 Jun 2023
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1038/s41467-023-39241-7
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @anisehay
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

nature.com/articles/s41467-023-39241-7
Feb 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer

1
1. scibot 04 Feb 2023
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1158/2326-6066.CIR-22-0088
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9357105/
Jun 2022
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

The SETDB1–TRIM28 complex suppresses antitumor immunity

1
1. scibot 07 Jun 2022
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1158/2326-6066.CIR-21-0754
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @bandrow
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8647838/
Feb 2022
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

The ratio of toxic-to-nontoxic microRNAs predicts platinum sensitivity in ovarian cancer

1
1. scibot 02 Feb 2022
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1158/0008-5472.CAN-21-0953
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8338879/
Dec 2021
www.sciencedirect.com www.sciencedirect.com

Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer

1
1. scibot 22 Dec 2021
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1016/j.xcrm.2021.100471
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379121003438
May 2021
www.sciencedirect.com www.sciencedirect.com

PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells

1
1. scibot 07 May 2021
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1016/j.molcel.2020.08.018
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1097276520305815
Sep 2020
www.sciencedirect.com www.sciencedirect.com

Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone

1
1. scibot 26 Sep 2020
  
  in Public
  
  RRID:CVCL_2690
  
  DOI: 10.1016/j.celrep.2020.107840
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:CVCL_2690

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124720308214
mcr.aacrjournals.org mcr.aacrjournals.org

EZH2 loss drives resistance to carboplatin and paclitaxel in serous ovarian cancers expressing ATM

1
1. scibot 03 Sep 2020
  
  in Public
  
  RRID: CVCL_2690
  
  DOI: 10.1158/1541-7786.MCR-19-0141
  
  Resource: (ECACC Cat# 10032309, RRID:CVCL_2690)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_2690
  
  What is this?
  
  RRID:CVCL_2690
Visit annotations in context

Tags

RRID:CVCL_2690

Annotators

scibot

URL

mcr.aacrjournals.org/content/18/2/278